This chapter outlines the important and common late-onset, long-term endocrine disorders that occur as a consequence of cancer therapy in survivors: bone metabolism disorders, metabolic (i.e., glucose and lipid) disorders, thyroid neoplasia and dysfunction, hypothalamic-pituitary dysfunction, adrenal dysfunction, and gonadal system disorders. Strategies for evaluating and managing these effects are included.
|Original language||English (US)|
|Title of host publication||Advances in Cancer Survivorship Management|
|Publisher||Springer New York|
|Number of pages||18|
|State||Published - Jan 1 2015|
ASJC Scopus subject areas